Terms: = Ovarian cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
178 results:
1.
Mulkidjan RS; Saitova ES; Preobrazhenskaya EV; Asadulaeva KA; Bubnov MG; Otradnova EA; Terina DM; Shulga SS; Martynenko DE; Semina MV; Belogubova EV; Tiurin VI; Amankwah PS; Martianov AS; Imyanitov EN
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686416
[TBL] [Abstract] [Full Text] [Related]
2. Cardiovascular Mortality in ovarian cancer Patients: An Analysis of Patient Characteristics Using the SEER Database.
Al-Badawi IA; Alomar O; Alsehaimi SO; Jamjoom MZ; Abdulmalik NA; Bukhari IA; Alyousef A; Alabdrabalamir S; Baradwan S; Sayasneh A; Alqarni SMS; Abu-Zaid A
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629766
[No Abstract] [Full Text] [Related]
3. Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI.
Dumont S; Vandecaveye V; Dresen RC; Van Nieuwenhuysen E; Baert T; Amant F; Broeckhoven V; Van Gorp T
Int J Gynecol Cancer; 2023 Dec; 33(12):1890-1897. PubMed ID: 37597854
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of alk overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
Gorczyński A; Miszewski K; Gager Y; Koch S; Pötschke J; Ugrinovski D; Gabert J; Pospieszyńska A; Wydra D; Duchnowska R; Szymanowski B; Cierniak S; Kruecken I; Neumann K; Mirkov K; Biernat W; Czapiewski P
Cancer Biomark; 2023; 38(1):17-26. PubMed ID: 37522200
[TBL] [Abstract] [Full Text] [Related]
5. SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Drilon A; Sharma MR; Johnson ML; Yap TA; Gadgeel S; Nepert D; Feng G; Reddy MB; Harney AS; Elsayed M; Cook AW; Wong CE; Hinklin RJ; Jiang Y; Brown EN; Neitzel NA; Laird ER; Wu WI; Singh A; Wei P; Ching KA; Gaudino JJ; Lee PA; Hartley DP; Rothenberg SM
Cancer Discov; 2023 Aug; 13(8):1789-1801. PubMed ID: 37269335
[TBL] [Abstract] [Full Text] [Related]
6. Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to ovarian cancer Cells.
Koren Carmi Y; Khamaisi H; Adawi R; Noyman E; Gopas J; Mahajna J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175439
[TBL] [Abstract] [Full Text] [Related]
7. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
[TBL] [Abstract] [Full Text] [Related]
8.
Bulutay P; Vatansever D; Taskiran C; Mericoz CA; Tokat F; Kapucuoglu N; Kulac I
Indian J Pathol Microbiol; 2023; 66(2):392-395. PubMed ID: 37077094
[TBL] [Abstract] [Full Text] [Related]
9. A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer.
Hawarden A; Price M; Russell B; Wilson G; Farrelly L; Embleton-Thirsk A; Parmar M; Edmondson R
PLoS One; 2023; 18(3):e0281798. PubMed ID: 36952534
[TBL] [Abstract] [Full Text] [Related]
10. Recent Updates on Structural Aspects of alk Inhibitors as an Anticancer Agent.
Ayaz MS; Bhupal R; Sharma P; Sahu A; Singh P; Gupta GD; Asati V
Anticancer Agents Med Chem; 2023; 23(8):900-921. PubMed ID: 36627781
[TBL] [Abstract] [Full Text] [Related]
11. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
12. Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial.
Lu LW; Chen NW; Brunder DG; Nayeem F; Nagamani M; Nishino TK; Anderson KE; Khamapirad T
Clin Nutr ESPEN; 2022 Dec; 52():158-168. PubMed ID: 36513449
[TBL] [Abstract] [Full Text] [Related]
13. Projection of cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older.
Hong Y; Lee S; Moon S; Sung S; Lim W; Kim K; An S; Choi J; Ko KP; Kim I; Lee JE; Park SK
J Prev Med Public Health; 2022 Nov; 55(6):529-538. PubMed ID: 36475318
[TBL] [Abstract] [Full Text] [Related]
14. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib.
Guo M; Shu Y; Chen G; Li J; Li F
Sci Rep; 2022 Nov; 12(1):20601. PubMed ID: 36446798
[TBL] [Abstract] [Full Text] [Related]
15. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer.
Bahado-Singh RO; Ibrahim A; Al-Wahab Z; Aydas B; Radhakrishna U; Yilmaz A; Vishweswaraiah S
Sci Rep; 2022 Nov; 12(1):18625. PubMed ID: 36329159
[TBL] [Abstract] [Full Text] [Related]
16. ovarian tissue cryopreservation and transplantation: 20 years experience in Bologna University.
Fabbri R; Vicenti R; Magnani V; Paradisi R; Lima M; De Meis L; Rossi S; Raimondo D; Casadio P; Venturoli S; Maffi M; Seracchioli R
Front Endocrinol (Lausanne); 2022; 13():1035109. PubMed ID: 36313739
[TBL] [Abstract] [Full Text] [Related]
17. Targeting the alk-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.
Chu YY; Chen MK; Wei Y; Lee HH; Xia W; Wang YN; Yam C; Hsu JL; Wang HL; Chang WC; Yamaguchi H; Jiang Z; Liu C; Li CF; Nie L; Chan LC; Gao Y; Wang SC; Liu J; Westin SN; Lee S; Sood AK; Yang L; Hortobagyi GN; Yu D; Hung MC
Nat Cancer; 2022 Oct; 3(10):1211-1227. PubMed ID: 36253486
[TBL] [Abstract] [Full Text] [Related]
18. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of a novel alk/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models.
Fang DD; Tao R; Wang G; Li Y; Zhang K; Xu C; Zhai G; Wang Q; Wang J; Tang C; Min P; Xiong D; Chen J; Wang S; Yang D; Zhai Y
BMC Cancer; 2022 Jul; 22(1):752. PubMed ID: 35820889
[TBL] [Abstract] [Full Text] [Related]
20. Pan-cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.
Che H; Jatsenko T; Lenaerts L; Dehaspe L; Vancoillie L; Brison N; Parijs I; Van Den Bogaert K; Fischerova D; Heremans R; Landolfo C; Testa AC; Vanderstichele A; Liekens L; Pomella V; Wozniak A; Dooms C; Wauters E; Hatse S; Punie K; Neven P; Wildiers H; Tejpar S; Lambrechts D; Coosemans A; Timmerman D; Vandenberghe P; Amant F; Vermeesch JR
Clin Chem; 2022 Sep; 68(9):1164-1176. PubMed ID: 35769009
[TBL] [Abstract] [Full Text] [Related]
[Next]
